Company news
ImmuPharma plc news in 2018
ImmuPharma plc's news releases, calls and decks from 2018, newest first.
Clinical Development Collaboration with Incanthera
December 31, 2018
Appointment of Nominated Adviser
December 17, 2018
Update on Corporate Activities
December 7, 2018
Nominated Adviser Status
November 1, 2018
Appointment of Joint Brokers
September 19, 2018
Results of CIDP Pre-Clinical Data
June 14, 2018
Notice of AGM & Posting of Annual Report
June 6, 2018
Update on Pivotal Phase III Trial of Lupuzor
May 29, 2018
Topline results of Lupuzor Pivotal Phase III Trial
April 17, 2018
Appointment of Joint Broker
March 28, 2018
Lupuzor Pivotal Phase III Study Update
March 23, 2018
AIM Notice (17)
March 5, 2018
London Investor Evening
February 15, 2018
Successful Placing to Raise £10 Million
January 24, 2018
Completion of LupuzorT Pivotal Phase III Study
January 18, 2018